Caissa Capital Management Ltd. Avalo Therapeutics, Inc. (AVTX) insider trading activity

AVTX Quotes by TradingView

Caissa Capital Management Ltd. is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AVTX, which is worth approximately $0. The most recent transaction as insider was on Jun 26, 2023, when has been sold 182,300 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $113,026. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Caissa Capital Management ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 26 2023
SELL
Open market or private purchase
$113,026 $0.62 p/Share
182,300 Reduced 100.0%
0 Common Stock
CCM

Caissa Capital Management Ltd.

> 10% Shareholder
Tortola, D8

Track Institutional and Insider Activities on AVTX

Follow Avalo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTX shares.

Notify only if

Insider Trading

Get notified when an Avalo Therapeutics, Inc. insider buys or sells AVTX shares.

Notify only if

News

Receive news related to Avalo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTX